Solin P, Roebuck T, Johns D P, Walters E H, Naughton M T
Department of Respiratory Medicine, The Alfred Hospital, Melbourne, Victoria, Australia.
Am J Respir Crit Care Med. 2000 Dec;162(6):2194-200. doi: 10.1164/ajrccm.162.6.2002024.
Given that the apnea-ventilation cycle length during central sleep apnea (CSA) with congestive heart failure (CHF) is approximately 70 s, we hypothesized that rapidly responsive peripheral CO(2) ventilatory responses would be raised in CHF-CSA and would correlate with the severity of CSA. Sleep studies and single breath and rebreathe hypercapnic ventilatory responses (HCVR) were measured as markers of peripheral and central CO(2) ventilatory responses, respectively, in 51 subjects: 12 CHF with no apnea (CHF-N), 8 CHF with obstructive sleep apnea (CHF-OSA), 12 CHF-CSA, 11 CSA without CHF ("idiopathic" CSA; ICSA), and 8 normal subjects. Single breath HCVR was equally elevated in CHF-CSA and ICSA groups compared with CHF-N, CHF-OSA, and normal groups (0.58 +/- 0.09 [mean +/- SE] and 0. 58 +/- 0.07 versus 0.23 +/- 0.06, 0.25 +/- 0.04, and 0.27 +/- 0.02 L/min/PET(CO(2)) mm Hg, respectively, p < 0.001). Similarly, rebreathe HCVR was elevated in both CHF-CSA and ICSA groups compared with CHF-N, CHF-OSA, and normal groups (5.80 +/- 1.12 and 3.53 +/- 0. 29 versus 2.00 +/- 0.25, 1.44 +/- 0.16, and 2.14 +/- 0.22 L/min/PET(CO(2)) mm Hg, respectively, p < 0.001). Furthermore, in the entire CHF group, single breath HCVR correlated with central apnea-hypopnea index (AHI) (r = 0.63, p < 0.001) and percentage central/total apneas (r = 0.52, p = 0.022). Rebreathe HCVR correlated with awake Pa(CO(2)) (r = -0.61, p < 0.001), but not with central AHI or percentage central/total apneas independent of its relationship with single breath HCVR. In conclusion, in subjects with CHF, raised central CO(2) ventilatory response predisposes to CSA promoting background hypocapnia and exposing the apnea threshold to fluctuations in ventilation, whereas raised and faster-acting peripheral CO(2) ventilatory response determines the periodicity and severity of CSA.
鉴于伴有充血性心力衰竭(CHF)的中枢性睡眠呼吸暂停(CSA)期间的呼吸暂停-通气周期长度约为70秒,我们推测CHF-CSA患者快速反应的外周CO₂通气反应会增强,且与CSA的严重程度相关。在51名受试者中分别测量了睡眠研究、单次呼吸和重复呼吸高碳酸通气反应(HCVR),作为外周和中枢CO₂通气反应的指标,这些受试者包括:12名无呼吸暂停的CHF患者(CHF-N)、8名伴有阻塞性睡眠呼吸暂停的CHF患者(CHF-OSA)、12名CHF-CSA患者、11名无CHF的CSA患者(“特发性”CSA;ICSA)以及8名正常受试者。与CHF-N、CHF-OSA和正常组相比,CHF-CSA组和ICSA组的单次呼吸HCVR均升高(分别为0.58±0.09[平均值±标准误]和0.58±0.07,而CHF-N组、CHF-OSA组和正常组分别为0.23±0.06、0.25±0.04和0.27±0.02L/min/PET(CO₂)mmHg,p<0.001)。同样,与CHF-N、CHF-OSA和正常组相比,CHF-CSA组和ICSA组的重复呼吸HCVR也升高(分别为5.80±1.12和3.53±0.29,而CHF-N组、CHF-OSA组和正常组分别为2.00±0.25、1.44±0.16和2.14±0.22L/min/PET(CO₂)mmHg,p<0.001)。此外,在整个CHF组中,单次呼吸HCVR与中枢呼吸暂停低通气指数(AHI)相关(r=0.63,p<0.001)以及中枢/总呼吸暂停百分比相关(r=0.52,p=0.022)。重复呼吸HCVR与清醒时的Pa(CO₂)相关(r=-0.61,p<0.001),但与中枢AHI或中枢/总呼吸暂停百分比无关,这独立于其与单次呼吸HCVR的关系。总之,在CHF患者中,中枢CO₂通气反应增强易导致CSA,促进背景性低碳酸血症,并使呼吸暂停阈值暴露于通气波动中,而外周CO₂通气反应增强且作用更快则决定了CSA的周期性和严重程度。